Albemarle (NYSE:ALB) Price Target Cut to $128.00

Albemarle (NYSE:ALB – Free Report) had its target price cut by Royal Bank of Canada from $157.00 to $128.00 in a report issued on Wednesday morning. They currently have an overweight rating on the specialty chemicals company’s stock. ALB has been the topic of a number of other reports. Wells Fargo & Company cut shares […]

Leave a Reply

Your email address will not be published.

Previous post Insider Selling: Tango Therapeutics, Inc. (NASDAQ:TNGX) Major Shareholder Sells $392,000.00 in Stock
Next post Sysco (NYSE:SYY) Given New $88.00 Price Target at Barclays